Skip to main content
. 2017 Oct 19;9:513–523. doi: 10.2147/CMAR.S147227

Table 3.

Survival data of 15 patients with appendiceal GCCs and PC

Survival Data
Ad mortem, n (%) 8 (53.3)
Median overall survival after diagnosis of PC, range (months) 28 (6.5–56)
Median overall survival after CRS/HIPEC, range (months) 17 (0.5–51)

Abbreviations: CRS, cytoreductive surgery; GCCs, goblet cell carcinomas; HIPEC, hyperthermic intraperitoneal chemotherapy; PC, peritoneal carcinomatosis.